Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%
Galmed Pharmaceuticals Ltd. GLMD was a big mover last session, as the company saw its shares jump nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $6.02 to $6.85 in the past one-month time frame.
The company has seen no positive or negative estimate revision in the past 30 days. But its Zacks Consensus Estimate moved higher over the last seven days. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Galmed Pharmaceuticals currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
Galmed Pharmaceuticals Ltd. Price
Galmed Pharmaceuticals Ltd. Price | Galmed Pharmaceuticals Ltd. Quote
A better-ranked stock in the Medical - Drugs industry is Advanced Accelerator Applications S.A. AAAP, which holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is GLMD going up? Or down? Predict to see what others think: Up or Down
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artifical intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Galmed Pharmaceuticals Ltd. (GLMD) : Free Stock Analysis Report
Advanced Accelerator Applications S.A. (AAAP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
